DunhamTrimmer Appoints Ignacio Moyano Cordoba as VP of Business Development for LATAM
DunhamTrimmer, a global leader in business intelligence for the biocontrol, biostimulant, biofertilizer, and specialized nutrition industries, announced the addition of Ignacio Moyano Córdoba as Vice President of Business Development for Latin America. With more than 20 years of experience in the agricultural sector, Ignacio has held strategic positions such as General Manager of Stoller Brazil, […]
Veracyte Announces Appointment of Brent Shafer and Tom Miller, Ph.D., to Its Board
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, recently announced the appointment of Brent Shafer and Tom Miller, Ph.D., to its board of directors, effective immediately. “We are thrilled to welcome Brent and Tom to our board,” said Marc Stapley, Veracyte’s chief executive officer. “They are both seasoned business leaders with extensive healthcare industry […]
Maryland Tech Council and BIOQuébec collaborate to promote life sciences
BIOQuébec and the Maryland Tech Council (MTC) are delighted to announce a new Memorandum of Understanding (MOU) that will enhance cooperation and collaboration between life sciences sectors in Québec and Maryland. This partnership aims to foster mutual benefits and strengthen biopharma and biotech industries in both regions through shared information and opportunities. The MOU establishes […]
Merck Signs MoU with KAIST to Further Scientific Partnership in South Korea
Merck, a leading science and technology company, has signed a non-binding Memorandum of Understanding (MoU) with the Korea Advanced Institute of Science and Technology (KAIST). The academia-industry cooperation aims to advance the research and development ecosystem in South Korea for industrial applications. “Our collaboration with KAIST is an important step towards accelerating the biotechnology ramp-up […]
Cognivia announces strategic EUR 15.5Mln funding
Cognivia, an innovative AI company dedicated to reshaping pharmaceutical and biotech clinical research through cutting edge AI-ML algorithms, announced a significant investment milestone. Vesalius Biocapital IV, SFPIM (Société Fédérale de Participations et d’Investissement) and WE (Wallonie Entreprendre) have committed strategic investments to drive Cognivia’s mission to “quantify the power of the mind” to optimize and […]
Kenai Therapeutics announces USD 82Mln series A financing
Kenai Therapeutics, a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and develop a platform of allogeneic neuron replacement cell therapies for neurological disorders, today announced an $82 million Series A financing co-led by Alaska Permanent Fund Corporation, Cure Ventures and The Column Group, with participation from Euclidean Capital and Saisei Ventures. […]
STEMCELL Technologies to acquire all assets of SQZ Biotechnologies Company
STEMCELL Technologies announced the acquisition of substantially all assets of SQZ Biotechnologies Company (SQZ)—a Massachusetts-based biotech known for its game-changing method of introducing a variety of therapeutic cargo into cells by squeezing them (mechanoporation) rather than using electricity (electroporation). This transaction, which was approved by SQZ shareholders today, marks another significant milestone for STEMCELL, Canada’s […]
Prothena appoints Daniel G. Welch as Director and Chair Designate
Prothena Corporation plc, a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, announced yesterday the appointment of Daniel G. Welch to its Board of Directors as an independent director and Chair Designate following a comprehensive search process in connection with the board’s regular succession planning. Upon election […]
Matica Bio designates Paul Kim as CEO
Matica Biotechnology, Inc., a contract development and manufacturing organization (CDMO) of cell and gene therapies (CGTs), yesterday announced the appointment of Paul Kim as chief executive officer (CEO). As incoming CEO, Kim will manage daily operations and provide strategic direction to Matica Bio as it rapidly expands its capacity and capabilities in the U.S. and […]
Molecular Partners and Orano Med collaborate to develop novel Radio-DARPin therapeutics
Molecular Partners AG, a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, and Orano Med, a pioneer in targeted alpha therapy, have announced a collaboration to develop novel Radio-DARPin therapeutics (RDTs) that use Orano Med’s 212Pb radioisotope as a payload to selectively kill cancer cells. Both companies will leverage their […]
